Close

Peregrine Pharma (PPHM), AstraZeneca (AZN) Expand Cancer Immunotherapy Collaboration

October 15, 2015 8:06 AM EDT Send to a Friend
Peregrine Pharma (NASDAQ: PPHM) announced that it has expanded its ongoing cancer immunotherapy clinical collaboration with AstraZeneca (NYSE: AZN) to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login